(Q34756810)

4 August 2017

Initiation of antiretroviral treatment in women after delivery can induce multiclass drug resistance in breastfeeding HIV-infected infants (English)

1 reference

4 August 2017

anti-retroviral agent

0 references

0 references

Newton I Kumwenda

5

0 references

Taha E. Taha

object named as

Taha E Taha

3

0 references

Lynne Mofenson

object named as

Lynne M Mofenson

6

0 references

Susan Eshleman

10

object named as

Susan H Eshleman

1 reference

4 August 2017

7

Johnstone J Kumwenda

1 reference

4 August 2017

8

Mary Glenn Fowler

1 reference

4 August 2017

1

Jessica Fogel

1 reference

4 August 2017

9

Michael C Thigpen

1 reference

4 August 2017

Qing Li

2

1 reference

PubMed ID

21460326

4 August 2017

Donald R Hoover

4

1 reference

PubMed ID

21460326

4 August 2017

language of work or name

English

0 references

publication date

1 April 2011

1 reference

Clinical Infectious Diseases

4 August 2017

1 reference

4 August 2017

52

1 reference

4 August 2017

1069-1076

1 reference

4 August 2017

8

1 reference

Slower clearance of nevirapine resistant virus in infants failing extended nevirapine prophylaxis for prevention of mother-to-child HIV transmission

4 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3070029

Antiretroviral regimens in pregnancy and breast-feeding in Botswana

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3070029

Maternal or infant antiretroviral drugs to reduce HIV-1 transmission

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3070029

Addition of extended zidovudine to extended nevirapine prophylaxis reduces nevirapine resistance in infants who were HIV-infected in utero

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3070029

Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3070029

Breastfeeding and AIDS in the developing world

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3070029

Nevirapine resistance and breast-milk HIV transmission: effects of single and extended-dose nevirapine prophylaxis in subtype C HIV-infected infants

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3070029

Antiretroviral concentrations in breast-feeding infants of mothers receiving highly active antiretroviral therapy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3070029

Early Antiretroviral Therapy and Mortality among HIV-Infected Infants

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3070029

Analysis of nevirapine (NVP) resistance in Ugandan infants who were HIV infected despite receiving single-Dose (SD) NVP versus SD NVP plus daily NVP up to 6 weeks of age to prevent HIV vertical transmission.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3070029

Hematologic and hepatic toxicities associated with antenatal and postnatal exposure to maternal highly active antiretroviral therapy among infants

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3070029

Extended-dose nevirapine to 6 weeks of age for infants to prevent HIV transmission via breastfeeding in Ethiopia, India, and Uganda: an analysis of three randomised controlled trials

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3070029

Effects of early, abrupt weaning on HIV-free survival of children in Zambia

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3070029

Antiretroviral concentrations in breast-feeding infants of women in Botswana receiving antiretroviral treatment

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3070029

Prevention of mother-to-child transmission of HIV-1 through breast-feeding by treating infants prophylactically with lamivudine in Dar es Salaam, Tanzania: the Mitra Study

7 July 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR008

Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR008

Prevention of mother-to-child transmission of HIV-1 through breastfeeding by treating mothers with triple antiretroviral therapy in Dar es Salaam, Tanzania: the Mitra Plus study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR008

The effects of zidovudine in the subset of infants infected with human immunodeficiency virus type-1 (Pediatric AIDS Clinical Trials Group Protocol 076).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR008

Protecting the Next Generation — Eliminating Perinatal HIV-1 Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR008

21 January 2018

Identifiers

DOI

10.1093/CID/CIR008

1 reference

4 August 2017

1 reference

4 August 2017

1 reference

PubMed ID

21460326